|
SH2D3C expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.635350E-03 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.428900E-04 |
| Normal-vs-Stage2 |
8.663600E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
4.351800E-02 |
| Stage1-vs-Stage2 |
5.936600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
1.702000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
2.741200E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.242700E-03 |
| Normal-vs-AfricanAmerican |
3.150200E-01 |
| Normal-vs-Asian |
1.140790E-01 |
| Caucasian-vs-AfricanAmerican |
7.438000E-01 |
| Caucasian-vs-Asian |
5.890400E-01 |
| AfricanAmerican-vs-Asian |
8.777200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.139900E-03 |
| Normal-vs-Female |
2.260100E-02 |
| Male-vs-Female |
4.192400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.379070E-04 |
| Normal-vs-Extreme_Weight |
9.865600E-02 |
| Normal-vs-Obese |
2.486300E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
7.288000E-01 |
| Normal_Weight-vs-Obese |
8.760200E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
6.930200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.319800E-02 |
| Normal-vs-Age(41-60Yrs) |
6.200600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.852000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.441000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.967400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.947600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.915000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.345200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.569600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.305400E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
2.003200E-01 |
| Normal-vs-Grade 3 |
4.302400E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
3.860800E-01 |
| Grade 2-vs-Grade 4 |
2.003200E-01 |
| Grade 3-vs-Grade 4 |
4.302400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.300100E-03 |
| Normal-vs-N1 |
1.189030E-01 |
| N0-vs-N1 |
5.551700E-02 |
|
|
